Monday, March 1, 2021

Compensating challenge vaccine trial participants: further discussion in the American Journal of Bioethics

 The AJB invites commentaries on its target articles, and the comments on our article on payments in human infection challenge trials have now appeared.  (If I've done this right, you can read them by clicking on the links below.) This is from The American Journal of Bioethics, Volume 21, Issue 3 (2021)

Our target article points out that while much of the medical ethics literature focuses on the claim that payments can subject potential participants, particularly poor people, to undue influence or coercion by being too large, there can be a countervailing concern that payments that are too small can be exploitative, and that this might often be the greater ethical concern.

The commentaries are all brief, but there are nine of them, so let me recommend to my regular market design readers that two that might be rewarding to begin with are those by Julian Savulescu, and by Seán O’Neill McPartlin & Josh Morrison.

Target Article
Open Peer Commentaries
Article commentary
Pages: 32-34
Published online: 22 Feb 2021
OpenURL
  • 7Views
  • 0CrossRef citations
  • 0Altmetric
Article commentary
Pages: 35-37
Published online: 22 Feb 2021
OpenURL
  • 2Views
  • 0CrossRef citations
  • 3Altmetric
Article commentary
Pages: 43-45
Published online: 22 Feb 2021
OpenURL
  • 2Views
  • 0CrossRef citations
  • 0Altmetric
Article commentary
Pages: 45-47
Published online: 22 Feb 2021
OpenURL
  • 13Views
  • 0CrossRef citations
  • 0Altmetric


Previous post:

No comments: